664 related articles for article (PubMed ID: 23479184)
21. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
[TBL] [Abstract][Full Text] [Related]
22. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
[TBL] [Abstract][Full Text] [Related]
23. Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
Gomar JJ; Conejero-Goldberg C; Davies P; Goldberg TE;
J Alzheimers Dis; 2016; 51(4):1085-97. PubMed ID: 26967213
[TBL] [Abstract][Full Text] [Related]
24. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW
Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267
[TBL] [Abstract][Full Text] [Related]
25. Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies.
Choe YM; Byun MS; Yi D; Lee JH; Jeon SY; Sohn BK; Kim YK; Shin SA; Sohn CH; Lee YJ; Lee DY;
Alzheimers Res Ther; 2019 Sep; 11(1):79. PubMed ID: 31511066
[TBL] [Abstract][Full Text] [Related]
26. Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease.
Olsson M; Ärlig J; Hedner J; Blennow K; Zetterberg H
Sleep; 2018 May; 41(5):. PubMed ID: 29425372
[TBL] [Abstract][Full Text] [Related]
27. Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial.
Ooms S; Overeem S; Besse K; Rikkert MO; Verbeek M; Claassen JA
JAMA Neurol; 2014 Aug; 71(8):971-7. PubMed ID: 24887018
[TBL] [Abstract][Full Text] [Related]
28. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
29. Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.
Varga AW; Wohlleber ME; Giménez S; Romero S; Alonso JF; Ducca EL; Kam K; Lewis C; Tanzi EB; Tweardy S; Kishi A; Parekh A; Fischer E; Gumb T; Alcolea D; Fortea J; Lleó A; Blennow K; Zetterberg H; Mosconi L; Glodzik L; Pirraglia E; Burschtin OE; de Leon MJ; Rapoport DM; Lu SE; Ayappa I; Osorio RS
Sleep; 2016 Nov; 39(11):2041-2048. PubMed ID: 27568802
[TBL] [Abstract][Full Text] [Related]
30. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
31. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M
J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084
[TBL] [Abstract][Full Text] [Related]
32. Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course.
Liguori C; Placidi F; Izzi F; Spanetta M; Mercuri NB; Di Pucchio A
Alzheimers Res Ther; 2020 Jan; 12(1):5. PubMed ID: 31901236
[TBL] [Abstract][Full Text] [Related]
33. Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker.
Lloret MA; Cervera-Ferri A; Nepomuceno M; Monllor P; Esteve D; Lloret A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050587
[TBL] [Abstract][Full Text] [Related]
34. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K
J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852
[TBL] [Abstract][Full Text] [Related]
35. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease.
Lim B; Fowler C; Li QX; Rowe C; Dhiman K; Gupta VB; Masters CL; Doecke JD; Martins RN; Collins S; Diamandis EP
Neurosci Lett; 2020 Jul; 731():135078. PubMed ID: 32450185
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal change of biomarkers in cognitive decline.
Lo RY; Hubbard AE; Shaw LM; Trojanowski JQ; Petersen RC; Aisen PS; Weiner MW; Jagust WJ;
Arch Neurol; 2011 Oct; 68(10):1257-66. PubMed ID: 21670386
[TBL] [Abstract][Full Text] [Related]
37. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
[TBL] [Abstract][Full Text] [Related]
38. Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.
Liguori C; Chiaravalloti A; Nuccetelli M; Izzi F; Sancesario G; Cimini A; Bernardini S; Schillaci O; Mercuri NB; Fabio P
J Neurol; 2017 Nov; 264(11):2215-2223. PubMed ID: 28900724
[TBL] [Abstract][Full Text] [Related]
39. Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease Patients.
Wams EJ; Wilcock GK; Foster RG; Wulff K
Curr Alzheimer Res; 2017; 14(10):1030-1041. PubMed ID: 28545363
[TBL] [Abstract][Full Text] [Related]
40. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]